Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye
Public Health Nursing · 2026
DOI: 10.1111/phn.70148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Public Health Nursing, 2026. Verfasst von Muhammet Salih Tarhan. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Mardin Training and Research Hospital, Mardin, Türkiye. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis C, Chronic, Hepatitis D, Chronic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study aimed to determine the seroprevalence of hepatitis B, C, and D in Mardin, Türkiye, identify at‐risk populations, and evaluate the effect of the hepatitis B vaccination program.
Methods
HBsAg, anti‐HBs, anti‐HBc IgG, anti‐HCV and anti‐HDV results were analysed retrospectively.
Results
Among the 30430 patients (60.2% female) tested, seropositivity rates were 2.1% for HBsAg, 55.2% for anti‐HBs, 27.8% for anti‐HBc IgG, and 0.14% for anti‐HCV; of HBsAg‐positive patients, 6.1% were anti‐HDV positive. After adjusting for Mardin's age distribution, the age‐weighted rates were 1.48%, 56.3%, 15.9%, 0.12%, and 6.2% (for anti‐HDV in adults). Those born after 1998 (aged ≤ 26), when hepatitis B vaccination began nationally, had significantly lower HBsAg (0.3% vs. 2.8%) and anti‐HBc IgG (2.5% vs. 36.6%) positivity, and higher anti‐HBs (59.1% vs. 53.4%) positivity, than older individuals ( p < 0.001). In a subgroup of 2703 with all hepatitis B markers, vaccine‐induced immunity was more frequent in those aged ≤ 26 years (55.4% vs. 22.0%), while natural immunity (1.5% vs. 26.7%) and chronic infection (0.6% vs. 4.9%) were more common in those aged ≥ 27 years ( p < 0.001).
Conclusion
This large‐scale survey in Mardin shows that hepatitis B vaccination reduced prevalence, highlighting the need for targeted screening and public health nursing interventions in older adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Mardin Training and Research Hospital, Mardin, Türkiye.
ORCID-Profile: Muhammet Salih Tarhan
Zitieren
APA
Tarhan, M. S. (2026). Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye. Public Health Nursing. https://doi.org/10.1111/phn.70148
Vancouver
Tarhan MS. Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye. Public Health Nursing. 2026. doi:10.1111/phn.70148
BibTeX
@article{Tarhan2026,
author = {Tarhan, Muhammet Salih},
title = {Determination of Seroprevalence of Chronic Hepatitis B, C and D: A Cross‐Sectional Study From Türkiye},
journal = {Public Health Nursing},
year = {2026},
doi = {10.1111/phn.70148}
}
EUVIMED